/Companies

ABBY by GOGOTECH

Techstars '21

Wilmington, US · 1 known investors

Find your way into ABBY by GOGOTECH

2,539 people in our graph share verified history with the ABBY by GOGOTECH team — schools, employers, funds. One of them is your warm intro.

Kalle Maijalaunlockedknows Dr. Clarence Tan · together at Bond University (overlapped)
knows the team · via Griffith University
×4knows the team · via USC Marshall School of Business
×6knows the team · via Techstars

GOGOTECH develops ABBY, a hybrid manual/power-assist/electric "smart" wheelchair with a smart controller, machine vision (cameras and sensors), and IoT cloud connectivity, priced below $4,000. The company plans to sell directly to consumers as a personal electric vehicle and, pending FDA 510(k) clearance, as a Class II medical device through B2B distributors, targeting both developed and developing markets.

Also known as Abby by GoGoTech · ABby By Gogotech INC. · ABBY by GOGOTECH Inc. · GOGOTECH

Founders & leadership

JD
John DeBenedetteFounder, CEO, Director
DC
Dr. Clarence TanCo-Founder and AdvisorDr. Clarence Tan is co-founder and advisor at GOGOTECH, which develops ABBY, a smart wheelchair with machine vision and IoT connectivity. His background spans education, startups, angel investing, and applications of artificial intelligence and data mining in finance and healthcare.

Investors · 1

Techstarslisted by TechstarsBoulder · $220K

How we know: the Techstars portfolio · press coverage · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us

Company profile

researched Sep 2026

ABBY by GOGOTECH Inc. is a Delaware C-corporation headquartered in Wilmington, Delaware that develops ABBY, a manual/power hybrid wheelchair positioned as a lower-cost alternative to conventional power chairs. The chair is lightweight and foldable, can be used manually or under power, and includes sensor-driven obstacle detection, cloud connectivity and app-based features that allow caregivers and family members to stay connected to the user. According to the company, its team designed a new wheelchair controller from scratch, which it describes as the first new controller design since the 1980s and the basis for adding sensor safety, robotics and connectivity features while holding down cost.

The company is pre-revenue. It positions ABBY as an expansion play in what it describes as a $14 billion wheelchair market, arguing that existing electric wheelchairs are expensive, in short supply and built on decades-old, heavy technology with slow-charging batteries that limit range and prevent manual use. Company materials list the product stage as full product ready, with assembly at a Shenzhen factory said to have capacity for 300 units per month, shipped FCL to a single US warehouse for centralized service, support and order fulfillment, initially through Amazon FBA and later through a combined warehouse, showroom and service center for multi-channel distribution.

Founding story

CEO John DeBenedette has used a wheelchair on and off since a 1985 motorcycle accident and spent close to a year in a wheelchair during rehabilitation. He describes that experience, combined with a software career, as the origin of the product: observing outdated technology and scarcity in the wheelchair industry, he set out to build an affordable motorized chair. Company materials also trace the effort to a desire to help people with reduced mobility in the founders' families and communities, and to the finding that electric wheelchairs are overpriced and in short supply.

Business model

Two channels are described: a direct-to-consumer online model selling ABBY as a personal electric vehicle, and, after FDA clearance, a B2B model selling the chair as a medical device through distributors for insurance reimbursement. As of the 2024 crowdfunding offering the company reported no revenue and no accounts receivable in its two most recent fiscal years, with the DTC model gearing up for production and the B2B model awaiting FDA 510(k) clearance.

Hardware sales of the ABBY wheelchair, direct to consumers online and, after regulatory clearance, through medical device distributors.

Traction

Pre-revenue with no reported sales in its two most recent fiscal years. Product stage is listed as full product ready, and stated manufacturing capacity is 300 units per month at the Shenzhen factory. The company has completed at least one closed Regulation CF campaign and a subsequent StartEngine offering.

Latest developments

A StartEngine equity crowdfunding offering at $0.52 per share, a stated $6M valuation and a $15K-$618K funding goal ran with a deadline of 9 January 2025 and is listed as closed. In November 2024 the CEO discussed the product and the campaign in a podcast interview.

▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies

Market position

The company frames itself as a challenger to what it calls the scarcity and high-price model of the roughly $14 billion wheelchair industry, seeking to make basic power chairs accessible to users whose needs are unmet by incumbents.

A hybrid design usable both manually and under power; a proprietary controller built from a clean slate rather than adapted from existing designs; sensor-based obstacle detection; cloud connectivity and companion app support for caregivers; lightweight, foldable construction; and a target price well below conventional power chairs.

Technology

A purpose-built wheelchair controller developed in-house, integrating robotics elements, sensor-driven safety and obstacle detection, and cloud connectivity with app-based remote support for caregivers and families.

Go-to-market

Initial direct-to-consumer online sales of the chair as a personal electric vehicle, with fulfillment beginning through Amazon FBA and later expanding to a company warehouse, showroom and service center for multi-channel distribution and domestic non-FBA fulfillment; medical device distribution through B2B partners is planned after FDA 510(k) clearance.

People with reduced mobility who are not wealthy or well-insured, including users in underdeveloped regions where a chair can be the difference between mobility and being bedridden; in the B2B channel, distributors serving insurance-reimbursed medical device buyers.

Geography

Headquarters in Wilmington, Delaware; manufacturing and assembly at a factory in Shenzhen, China; a single US warehouse for service, support and fulfillment. A job-board listing also associates the company with Bangkok, Thailand and Tenafly, New Jersey.

History

ABBY by GOGOTECH Inc. was incorporated in Delaware on 2 September 2021. It filed a Regulation Crowdfunding offering through Wefunder Portal LLC in August 2022, using SAFE securities, with the campaign opening 26 August 2022 and closing 30 April 2023. A further equity crowdfunding round was offered on StartEngine with a deadline of 9 January 2025; that offering is shown as closed.

Risks & controversies

The company is pre-revenue with minimal cash ($7,117 at its most recent fiscal year-end) against long-term debt of $618,383, and its B2B medical device channel cannot begin until FDA 510(k) clearance is obtained. The offering documentation notes the investment is speculative and illiquid, with risk of total loss.

Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Cash and equivalentsJan 2023$7.1K
EmployeesJan 20242 people
Long term debtJan 2023$618.4K
Manufacturing capacityNov 2024300 units per month
Product stageJan 2024Full Product Ready
RevenueJan 20230 USD
Target market sizeJan 2024$14B
Total assetsJan 2023$157.7K

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 3

launches, deals, and filings
Jan 2025
StartEngine Reg CF offering closes

An equity crowdfunding offering on StartEngine for common stock at $0.52 per share, with a stated $6M valuation and a funding goal range of $15,000 to $618,000, carried a deadline of 9 January 2025 and is listed as closed.

source ↗

Apr 2023
Closes Wefunder Regulation CF round

The company's Regulation CF SAFE campaign on Wefunder closed on 30 April 2023 after 247 days open, with $256,306 reported raised.

$256.3K source ↗

Aug 2022
Opens Regulation CF campaign on Wefunder

ABBY by GOGOTECH Inc. filed a Form C with the SEC in August 2022 for a Regulation Crowdfunding offering through Wefunder Portal LLC, offering SAFEs with a target of $50,000 and a maximum of $1,070,000, with a deadline of 30 April 2023. The campaign opened 26 August 2022.

$50K source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

▸Research sources · 7

primary sources listed

7 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does ABBY by GOGOTECH do?
ABBY by GOGOTECH develops a low-cost hybrid manual/power smart wheelchair sold direct-to-consumer and, pending FDA clearance, via distributors.
Who founded ABBY by GOGOTECH?
ABBY by GOGOTECH was founded by John DeBenedette, Dr. Clarence Tan.
Who are ABBY by GOGOTECH's investors?
ABBY by GOGOTECH's investors include Techstars.
Where is ABBY by GOGOTECH headquartered?
ABBY by GOGOTECH is headquartered in Wilmington, US.